US EditionPublished • loading... • Updated
Mérieux Equity Partners cedes Theravia after making it one of the European leaders in rare diseases
Summary by L'AGEFI
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All shares held in the Mérieux Participations 3 fund will be purchased by Norgine, a European midpharma owned by Goldman Sachs Asset Management.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
